HBK Investments’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

HBK Investments’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-635,960	Closed	-$201M	–	258
2023 Q4	$201M	Buy	+635,960	New	+$124M	0.92%	7

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

HBK Investments's KRTX Position: Q1 2024 in Review

HBK Investments sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 635,960 shares — an estimated $201M sold.

HBK Investments first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $201M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

HBK Investments reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
HBK Investments sold 635,960 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $201M.
HBK Investments first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
HBK Investments's Karuna Therapeutics, Inc. Common Stock position peaked at $201M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on HBK Investments's 13F filing for Q1 2024, filed 15 May 2024.